Our Clinical Research Capabilities
//
Our Clinical Research Capabilities
PRC Clinical’s CRO services support sponsors developing drugs, biologics, stem cell, gene therapies and medical devices.
With decades of expertise in clinical trial management and a team of experts, we provide customized solutions to ensure the success of your project.
PRC Clinical has over 20 years of experience in managing clinical research operations across various therapeutic areas and therapies. Our team has expertise in conducting first-in-human (FIH), Phase II and Phase III pharma/small molecule trials across many therapeutic areas.
Request More Information
We are committed to advancing biologic and regenerative medicine trials that have the potential to cure. Our experience includes a wide range of indications such as ageing, CNS and degenerative conditions to childhood treatments. PRC is proud to be at the forefront of biotechnology research providing early phase guidance for first-in-human trials, or supporting the complex nature of these trials that involve cell/gene transplants and the logistics, care and attention necessary to successfully complete the study.
Request More Information
PRC also supports medical device sponsors in their efforts to bring innovative products to market. Our team of experts provides comprehensive regulatory and clinical trial services to ensure compliance with all applicable regulations and standards. We have supported a variety of device and device-drug combination products including stents, implanted pumps, novel delivery systems as a well as diagnostic equipment studies.
Request More Information
PRC provides seamless mid-study transfer services to pharma and biotech clients who need to take existing studies from less than optimal or failing circumstances. With pre-built tools and expertise, we ensure a smooth transition and help our clients get their studies back on track.
Request More Information